| Design, synthesis, molecular modelling, ADME prediction and anti-hyperglycemic evaluation of new pyrazole-triazolopyrimidine hybrids as potent α-glucosidase inhibitors V Pogaku, K Gangarapu, S Basavoju, KK Tatapudi, SB Katragadda Bioorganic chemistry 93, 103307, 2019 | 67 | 2019 |
| Ultrasonication-ionic liquid synergy for the synthesis of new potent anti-tuberculosis 1, 2, 4-triazol-1-yl-pyrazole based spirooxindolopyrrolizidines V Pogaku, VS Krishna, D Sriram, K Rangan, S Basavoju Bioorganic & Medicinal Chemistry Letters 29 (13), 1682-1687, 2019 | 44 | 2019 |
| The design and green synthesis of novel benzotriazoloquinolinyl spirooxindolopyrrolizidines: Antimycobacterial and antiproliferative studies V Pogaku, VS Krishna, C Balachandran, K Rangan, D Sriram, S Aoki, ... New Journal of Chemistry 43 (44), 17511-17520, 2019 | 21 | 2019 |
| Sacubitril‐Based Urea and Thiourea Derivatives as Novel Inhibitors for Anti‐Tubercular against Dormant Tuberculosis S Konduri, V Pogaku, J Prashanth, V Siva Krishna, D Sriram, S Basavoju, ... ChemistrySelect 6 (16), 3869-3874, 2021 | 17 | 2021 |
| Synthesis and biological evaluation of novel triazole substituted pyrazolyl-methylenehydrazinyl-5-arylidene thiazolidinone derivatives as antibacterial and cytotoxic agents V Pogaku, RK Eslavath, G Dayakar, SS Singh, S Basavoju Research on Chemical Intermediates 43, 6079-6098, 2017 | 10 | 2017 |
| Synthesis and biological evaluation of new benzo[d][1,2,3]triazol-1-yl-pyrazole-based dihydro-[1,2,4]triazolo[4,3-a]pyrimidines as potent antidiabetic, anticancer … V Pogaku, R Krishnan, S Basavoju Research on Chemical Intermediates 47, 551-571, 2021 | 9 | 2021 |
